CDC STD Guidelines
Most infections among men produce symptoms that cause them to seek curative treatment. Among women, many infections do not produce recognizable symptoms until complications (PID) have occurred.
DNA amplification, swab/urine (last void >1 hour); be sure to test all sites of exposure, including pharyngeal and anal sites.
Because of increasing resistance, dual therapy is recommended when gonorrhea is diagnosed.
Recommended regimens for gonococcal infections of the cervix, urethra, pharynx, and rectum:
Ceftriaxone 250 mg IM in a single dose,
Azithromycin 1 g orally in a single dose
Notes: If patient with pharyngeal GC is treated with an alternative treatment regimen, repeat testing should be done at 2 weeks. If symptoms persist or follow-up testing is positive, culture/susceptibility testing should also be performed. Sexual partners within the previous 60 days of symptoms or diagnosis should be evaluated and treated. Rescreening is recommended 3 months after treatment since reinfection is highly prevalent in both men and women.